Enrofloxacin EP Impurity F is a structurally related fluoroquinolone derivative characterized by a 4-oxo-1,4-dihydroquinoline-3-carboxylic acid scaffold with a fluorine substituent at position 6 and a 7-piperazin-1-yl group. It features a hydroxyl substitution at the C-8 position, distinguishing it from the parent drug. This impurity arises via oxidative degradation pathways, introducing a hydroxyl group into the quinolone core. It serves as a critical HPLC reference standard for quantifying process-related impurities in enrofloxacin active pharmaceutical ingredients.
On RequestCCN1CCN(CC1)C2=C(C=C3C(=O)C=CN(C3=C2)C4CC4)F
InChI=1S/C18H22FN3O/c1-2-20-7-9-21(10-8-20)17-12-16-14(11-15(17)19)18(23)5-6-22(16)13-3-4-13/h5-6,11-13H,2-4,7-10H2,1H3
MHZWALDGPXSPGF-UHFFFAOYSA-N